Home
/
Oscar Health, Inc.
/
Financials
/
Quarterly
Oscar Health, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Oscar Health, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.99B
Nov 6, 2025
Q2
2025
Jun 30, 2025
$2.86B
Aug 7, 2025
Q1
2025
Mar 31, 2025
$3.05B
May 8, 2025
Q3
2025
Sep 30, 2024
$2.42B
Nov 6, 2025
Q2
2025
Jun 30, 2024
$2.22B
Aug 7, 2025
Q1
2025
Mar 31, 2024
$2.14B
May 8, 2025
Q3
2024
Sep 30, 2023
$1.44B
Nov 7, 2024
Q2
2024
Jun 30, 2023
$1.52B
Aug 7, 2024
Q1
2024
Mar 31, 2023
$1.47B
May 7, 2024
Q3
2023
Sep 30, 2022
$978.43M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$1.02B
Aug 9, 2023
Q1
2023
Mar 31, 2022
$972.77M
May 10, 2023
Q3
2022
Sep 30, 2021
$443.98M
Nov 9, 2022
Q1
2021
Jun 30, 2021
$529.28M
Aug 13, 2021
Q2
2022
Jun 30, 2021
$529.28M
Aug 12, 2022
Q1
2022
Mar 31, 2021
$369.39M
May 12, 2022
Q3
2021
Sep 30, 2020
$101.70M
Nov 12, 2021
Q1
2021
Jun 30, 2020
$115.33M
Aug 13, 2021
Q1
2021
Mar 31, 2020
$88.10M
May 14, 2021
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$8.80M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$6.50M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$4.33M
May 8, 2025
Q3
2025
Sep 30, 2024
$4.90M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$5.23M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$5.63M
May 8, 2025
Q3
2024
Sep 30, 2023
$5.54M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$5.09M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$5.00M
May 7, 2024
Q3
2023
Sep 30, 2022
$19.42M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$20.45M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$18.49M
May 10, 2023
Q3
2022
Sep 30, 2021
$1.55M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$353.0K
Aug 12, 2022
Q1
2022
Mar 31, 2021
$341.0K
May 12, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($137.45M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($228.36M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
$275.27M
May 8, 2025
Q3
2025
Sep 30, 2024
($54.60M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
$56.21M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$177.37M
May 8, 2025
Q3
2024
Sep 30, 2023
($65.40M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($15.53M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($39.77M)
May 7, 2024
Q3
2023
Sep 30, 2022
($192.91M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($112.16M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($75.15M)
May 10, 2023
Q3
2022
Sep 30, 2021
($211.48M)
Nov 9, 2022
Q3
2021
Jun 30, 2021
($73.07M)
Nov 12, 2021
Q2
2022
Jun 30, 2021
($73.32M)
Aug 12, 2022
Q1
2021
Jun 30, 2021
($73.07M)
Aug 13, 2021
Q3
2021
Mar 31, 2021
($87.37M)
Nov 12, 2021
Q1
2022
Mar 31, 2021
($88.88M)
May 12, 2022
Q3
2021
Sep 30, 2020
($79.13M)
Nov 12, 2021
Q3
2021
Jun 30, 2020
($40.94M)
Nov 12, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($129.25M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($230.48M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
$297.12M
May 8, 2025
Q3
2025
Sep 30, 2024
($48.37M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
$67.81M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$185.56M
May 8, 2025
Q3
2024
Sep 30, 2023
($58.24M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($6.53M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($25.37M)
May 7, 2024
Q3
2023
Sep 30, 2022
($192.37M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($106.49M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($68.53M)
May 10, 2023
Q3
2022
Sep 30, 2021
($211.68M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($72.51M)
Aug 12, 2022
Q1
2021
Jun 30, 2021
($72.25M)
Aug 13, 2021
Q1
2022
Mar 31, 2021
($64.04M)
May 12, 2022
Q3
2021
Sep 30, 2020
($80.13M)
Nov 12, 2021
Q1
2021
Jun 30, 2020
($39.35M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($95.95M)
May 14, 2021